Novartis’s Tschudin On Launches, Drug Pricing And Lasting COVID Impacts

Part 1 Of An Interview With Novartis Pharmaceuticals President

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.